Biotech Stocks


3 “Strong Buy” Biotech Stocks That Recently Went Public

This year has seen more than its share of successful IPOs – and some giant flops. The extremes should have been expected, in …

Are These 5 Biotech Stocks About to Get Bought Out?

In a previous article, I talked about the so-called patent cliff and the correlation to the pace of mergers and acquisitions in the pharma …

3 Biotech Stocks That Could Explode Higher in 2019

Black Friday is past. So is Cyber Monday.

Here Are My Top 3 Biotech Stocks

By Genia Turanova There’s nothing like cash to show how successful a company has been. When a fledgling enterprise first turns cash-flow positive …

Spectrum Pharmaceuticals’ (SPPI) Encouraging Clinical Update in NSCLC Gets the Bulls in a Buying Frenzy

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) just riled up Wall Street today with enticing Phase 2 study results in non-small cell lung cancer (NSCLC), sending …

What’s in Store for Incyte Corporation (INCY) After “Big Time” Clinical Miss? Reni Benjamin Chimes In

Raymond James’ Reni Benjamin may scale back his expectations on INCY, but still bets on 24% in return potential for shares.

Why This Analyst No Longer Makes a Bearish Call on Valeant Pharmaceuticals (VRX)

Mizuho’s Irina Rivkind Koffler has gotten more upbeat on the VRX name, but her raised expectations watch for 6% in loss potential for the stock.

Do Scpharmaceuticals (SCPH) and Rigel Pharmaceuticals (RIGL) Have Winning Catalysts Ahead? Analysts Say Yes

With SCPH standing before the FDA this summer and RIGL in less than two weeks’ time, two bulls are placing their bets behind these drug makers.

Eleven Biotherapeutics Inc’s (EBIO) Positive Phase 3 Trial Data in NMIBC Sends Investors on a Buying Frenzy

Eleven Biotherapeutics Inc (NASDAQ:EBIO) shares are jumping up like wildfire today on back of an encouraging Phase 3 trial data preview in bladder …

Valeant Pharmaceuticals Intl Inc (VRX) Subsidary Salix Wins Over Support of IBS Awareness Month Founders for New National Campaign

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) wholly owned subsidiary Salix is fostering a new two-way conversation between health care providers and irritable bowel syndrome …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts